Trevi Therapeutics (TRVI) Non-cash Items (2018 - 2026)

Trevi Therapeutics has reported Non-cash Items for 9 years, with the latest figure at $5.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 39.92% year-over-year to $5.9 million; the trailing twelve-month figure through Mar 2026 stood at $5.9 million (up 39.92% YoY), and the FY2025 full-year result was $5.2 million, up 38.75% from the prior year.
• Non-cash Items for Q1 2026 stood at $5.9 million, up from $5.2 million in the prior quarter.
• The five-year high for Non-cash Items was $11.7 million in Q4 2024, with the low at $685000.0 in Q4 2023.
• Average Non-cash Items over 5 years is $3.7 million, with a median of $3.3 million recorded in 2024.
• Year-over-year, Non-cash Items tumbled 68.81% in 2023 and surged 1603.5% in 2024.
• Tracing TRVI's Non-cash Items over 5 years: stood at $2.2 million in 2022, then plunged by 68.81% to $685000.0 in 2023, then surged by 1603.5% to $11.7 million in 2024, then plunged by 55.61% to $5.2 million in 2025, then grew by 14.26% to $5.9 million in 2026.
• The last three Non-cash Items figures came in at $5.9 million (Q1 2026), $5.2 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.

Peer Comparison